Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors

The adenosine receptor (AR) subtypes A2A and A2B are rhodopsin-like Gs protein-coupled receptors whose expression is highly regulated under pathological, e.g. hypoxic, ischemic and inflammatory conditions. Both receptors play important roles in inflammatory and neurodegenerative diseases, are blocked by caffeine, and have now become major drug targets in immuno-oncology. By Förster resonance energy transfer (FRET), bioluminescence resonance energy transfer (BRET), bimolecular fluorescence complementation (BiFC) and proximity ligation assays (PLA) we demonstrated A2A-A2BAR heteromeric complex formation. Moreover we observed a dramatically altered pharmacology of the A2AAR when co-expressed with the A2BAR (A2B ≥ A2A) in recombinant as well as in native cells. In the presence of A2BARs, A2A-selective ligands lost high affinity binding to A2AARs and displayed strongly reduced potency in cAMP accumulation and dynamic mass redistribution (DMR) assays. These results have major implications for the use of A2AAR ligands as drugs as they will fail to modulate the receptor in an A2A-A2B heteromer context. Accordingly, A2A-A2BAR heteromers represent novel pharmacological targets.

[1]  K. Brodsky,et al.  Identification of Hypoxia-Inducible Factor HIF-1A as Transcriptional Regulator of the A2B Adenosine Receptor during Acute Lung Injury , 2014, The Journal of Immunology.

[2]  J. Linden,et al.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.

[3]  K. Fuxe,et al.  G protein-coupled receptor heterodimerization in the brain. , 2013, Methods in enzymology.

[4]  I. Biaggioni,et al.  Role of adenosine A(2B) receptors in inflammation. , 2011, Advances in pharmacology.

[5]  C. Müller,et al.  Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors , 2014, Nature.

[6]  B. Fredholm,et al.  Adenosine receptors as drug targets — what are the challenges? , 2013, Nature Reviews Drug Discovery.

[7]  M. Sitkovsky,et al.  Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor* , 2010, The Journal of Biological Chemistry.

[8]  Francesca Fanelli,et al.  Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization , 2003, Journal of Biological Chemistry.

[9]  Stephen P. H. Alexander,et al.  An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells , 1997, British journal of pharmacology.

[10]  J. Selent,et al.  Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. , 2011, Current medicinal chemistry.

[11]  M. Aghaei,et al.  Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell lines , 2015, Research in pharmaceutical sciences.

[12]  Farag F. Sherbiny,et al.  The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function. , 2011, Biochemical pharmacology.

[13]  D. Ruff,et al.  Proximity assays for sensitive quantification of proteins , 2015, Biomolecular detection and quantification.

[14]  D. Möller,et al.  Structure-guided development of heterodimer-selective GPCR ligands , 2016, Nature Communications.

[15]  K. Jacobson,et al.  A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. , 1992, Molecular pharmacology.

[16]  K. Fuxe,et al.  Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.

[17]  Michel Bouvier,et al.  Building a new conceptual framework for receptor heteromers. , 2009, Nature chemical biology.

[18]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[19]  Lakshmi A Devi,et al.  AT1R–CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II , 2011, The EMBO journal.

[20]  K. Fuxe,et al.  Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment. , 2014, Current protein & peptide science.

[21]  K. Klotz,et al.  Human breast cancer cell line MDA‐MB‐231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal , 2005, British journal of pharmacology.

[22]  I. Palomo,et al.  Role of adenosine A2b receptor overexpression in tumor progression. , 2016, Life sciences.

[23]  Y. Shyu,et al.  Visualization of ternary complexes in living cells by using a BiFC-based FRET assay , 2008, Nature Protocols.

[24]  Chang‐Deng Hu,et al.  Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. , 2002, Molecular cell.

[25]  T. Voyno-Yasenetskaya,et al.  Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation , 2002, Circulation research.

[26]  L. Buée,et al.  The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function , 2016, Scientific Reports.

[27]  Chunhong Ma,et al.  HIF‐dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2‐stimulating phenotype under hypoxia , 2010, Immunology and cell biology.

[28]  C. Müller,et al.  BAY60-6583 Acts as a Partial Agonist at Adenosine A2B Receptors , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[29]  C. Müller,et al.  Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  T. Kerppola,et al.  Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells , 2006, Nature Protocols.

[31]  A. Schiedel,et al.  Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms , 2013, Purinergic Signalling.

[32]  I. Modlin,et al.  Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy , 2011, Purinergic Signalling.

[33]  K. Jacobson,et al.  Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor. , 2014, Biochemical pharmacology.

[34]  K. Ravid,et al.  Adenosine and blood platelets , 2011, Purinergic Signalling.

[35]  J. Mallol,et al.  Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine , 2015, The Journal of Neuroscience.

[36]  Y. Liu,et al.  Methods used to study the oligomeric structure of G-protein-coupled receptors , 2017, Bioscience reports.

[37]  J. Linden,et al.  Regulation of lymphocyte function by adenosine. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Leigh A. Stoddart,et al.  Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  J. Auchampach,et al.  Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling. , 2013, Cellular signalling.

[40]  B. Fredholm,et al.  Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[41]  A. Ohta,et al.  Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells , 2008, British journal of pharmacology.

[42]  Thomas Borrmann,et al.  1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. , 2009, Journal of medicinal chemistry.

[43]  A. Schiedel,et al.  Role of extracellular cysteine residues in the adenosine A2A receptor , 2016, Purinergic Signalling.

[44]  B. Fredholm,et al.  A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. , 1990, Analytical biochemistry.

[45]  K. Jacobson,et al.  A2B adenosine receptor blockade inhibits growth of prostate cancer cells , 2013, Purinergic Signalling.

[46]  Céline Galés,et al.  Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling. , 2015, Nature chemical biology.

[47]  K. Fuxe,et al.  Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices. , 2010, Biochemical and biophysical research communications.

[48]  M. Mirabet,et al.  Calcium mobilization in Jurkat cells via A2b adenosine receptors , 1997, British journal of pharmacology.

[49]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[50]  I. Biaggioni,et al.  Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype , 2004, Hypertension.

[51]  Victoria J. McIntosh,et al.  Differential effects of adenosine A2a and A2b receptors on cardiac contractility. , 2010, American journal of physiology. Heart and circulatory physiology.

[52]  L. Antonioli,et al.  Myeloid cells in the tumor microenvironment: Role of adenosine , 2016, Oncoimmunology.

[53]  R. González-Ramírez,et al.  Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells , 2016, PloS one.

[54]  B. Fredholm,et al.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update , 2011, Pharmacological Reviews.

[55]  R. Simpson.  Homogenization of mammalian tissue. , 2010, Cold Spring Harbor protocols.

[56]  B. Fredholm,et al.  Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[57]  C. Correll,et al.  Characterization of adenosine receptors in the human bladder carcinoma T24 cell line. , 2006, European journal of pharmacology.

[58]  Farag F. Sherbiny,et al.  The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors. , 2013, Biochemical pharmacology.

[59]  J. Pines,et al.  A quantitative protocol for dynamic measurements of protein interactions by Förster resonance energy transfer-sensitized fluorescence emission , 2009, Journal of The Royal Society Interface.

[60]  I. Biaggioni,et al.  Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. , 1998, Biochemical pharmacology.

[61]  Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs , 2016, BMC Biology.

[62]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[63]  J. Javitch,et al.  Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. , 2011, BioTechniques.

[64]  S. V. Kulgod,et al.  Protein determination by ponceau S using digital color image analysis of protein spots on nitrocellulose membranes. , 1999, Analytical biochemistry.

[65]  D. Ojcius,et al.  The Danger Signal Adenosine Induces Persistence of Chlamydial Infection through Stimulation of A2b Receptors , 2009, PloS one.

[66]  E. Granieri,et al.  A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[67]  E. Granieri,et al.  Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated , 2013, European journal of immunology.

[68]  N. Volkow,et al.  Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer , 2015, Proceedings of the National Academy of Sciences.